ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 753

Validation Of The New Histopathological Classification Of ANCA Glomerulonephritis and Its Association With Renal Outcomes In a Paediatric Population

Marinka Twilt1, Damien Noone2, Wesley Hayes2, Paul Thorner3, Susanne M. Benseler4, Ronald M. Laxer4, Rulan Parekh2 and Diane Hebert2, 1Pediatric Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Nephrology, The Hospital for Sick Children, Toronto, ON, Canada, 3Pathology, The Hospital for Sick Children, Toronto, ON, Canada, 4Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ANCA, glomerulonephritis, histopathologic and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated glomerulonephritides (ANCA GN) include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and Churg-Strauss. A novel histopathologic classification for GPA and MPA has been proposed and validated in adult populations and found to be predictive of long-term renal outcome. We aimed to validate this classification system in a paediatric population and identify clinical predictors of renal outcome. 

Methods:

We performed a retrospective review of all patients with ANCA GN, diagnosed and followed up until transfer to an adult centre at the Hospital for Sick Children between 1987 and 2012. Renal biopsies were reviewed by a pathologist blinded to patient outcome and classified using the new histopathological classification system of focal, crescentic, mixed, sclerotic and globally sclerotic groups. We determined time to CKD by estimated glomerular filtration rate (eGFR) with repeated creatinine measures using the Schwartz equation, or end stage kidney disease as defined as dialysis dependant. Survival and linear regression analyses were conducted.

Results:

The study population consisted of 42 children (69% male) with ANCA GN (21 GPA, 21 MPA) with a median age of 11.96 (+3.52) years and eGFR 36.6 mls/min/1.73m2 (IQR 15-87.4). Of the 40 patients with a renal biopsy at time of initial diagnosis, 12 (30%) had focal lesions, 20 (50%) crescentic, 3 (7.5%) mixed, 5 (12.5%) sclerotic and no globally sclerotic lesions.  13 (31 %) patients required dialysis at baseline. Survival analysis of time to the composite renal endpoint of at least 3 months of eGFR < 60 ml/min/1.73 m2 or ESKD differed among all 3 biopsy groups [p (logrank) = 0.0001; figure]. Probability (95% CI) of having an eGFR < 60 mls/min/1.73m2 at 2 years was 58.5% (35.1 – 76.0%) in the crescentic/mixed group. The sclerotic group all progressed to ESKD. Linear regression analysis demonstrated an association with slope of eGFR with baseline eGFR (p=0.01), baseline proteinuria (p=0.037) and need for dialysis (p<0.001) after adjustment. 

Conclusion:

We demonstrate the clinical utility of the new new histopathologic classification system and its ability to clearly discriminate outcomes among paediatric ANCA GN patients. Additional factors predicting outcome include baseline eGFR and dialysis. The new classification can be adopted for both clinical use and research studies.


Disclosure:

M. Twilt,
None;

D. Noone,
None;

W. Hayes,
None;

P. Thorner,
None;

S. M. Benseler,
None;

R. M. Laxer,
None;

R. Parekh,
None;

D. Hebert,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-new-histopathological-classification-of-anca-glomerulonephritis-and-its-association-with-renal-outcomes-in-a-paediatric-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology